Barriers to effective postmenopausal osteoporosis treatment: A qualitative study of patients' and practitioners' views

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Alami, Sophie ^a   Hervouet, Lucile ^b   Poiraudeau, Serge ^c   Briot, Karine ^c   Roux, Christian ^c  

^a Interlis ^*  (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DENOSUMAB; PARATHYROID HORMONE[1-34]; RALOXIFENE; STRONTIUM RANELATE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE INJURY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRAGILITY FRACTURE; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; MORBIDITY; PATIENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICIAN; POSTMENOPAUSE OSTEOPOROSIS; QUALITATIVE RESEARCH; RISK FACTOR; VERY ELDERLY; ATTITUDE TO HEALTH; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PHYSICIANS; QUALITATIVE RESEARCH; RISK FACTORS;

EID: 84977636305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158365     Document Type: Article

References (45)

1. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006; 35: 293-305. PMID: 16616152
2. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010; 58: 650-657. doi: 10.1111/j.1532-5415.2010.02769.x PMID: 20398147
3. Fraser LA, Ionnidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, et al. CaMos Research Group. Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2011; 22: 789-796. PMID: 20683706
4. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC. National Osteoporosis Foundation. 2014. Available: http://nof.org/files/nof/public/content/file/2791/upload/919.pdf.
5. Leslie WD, Giangregorio LM, Yogendran M, Azimaee M, Morin S, Metge C, et al. A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving. Osteoporos Int. 2012; 23: 1623-1629. doi: 10.1007/s00198-011-1630-1 PMID: 21476038
6. Balasubramanian A, Tosi LL, Lane JM, Dirschl DR, Ho PR, O'Malley CD. Declining rates of osteoporosis management following fragility fractures in the U.S, 2000 through 2009. J Bone Joint Surg Am. 2014; 96: 1-8.
7. Wysowski DK, Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. Bone. 2013; 57: 423-428. doi: 10.1016/j.bone.2013.09.008 PMID: 24063946
8. Solomon DH, Johnston SS, Boytsov NN, Mc Morrow D, Lane JM, Krohn KD. Osteoporosis medication use after hip fracture in US patients between 2002 and 2011. J Bone Miner Res. 2014; 29: 1929-1937. doi: 10.1002/jbmr.2202 PMID: 24535775
9. Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013; 8: 136. doi: 10.1007/s11657-013-0136-1 PMID: 24113837
10. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2004; 15: 721-739.
11. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkenjers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010; 152: 380-390. doi: 10.7326/0003-4819-152-6-201003160-00008 PMID: 20231569
12. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009; 301: 513-521. doi: 10.1001/jama.2009.50 PMID: 19190316
13. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR, et al. Vertebral fractures and mortality in older women. Arch Intern Med. 1999; 159: 1215-1220. PMID: 10371229
14. Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JA. Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res. 2013; 28: 2317-2324. doi: 10.1002/jbmr.1968 PMID: 23616397
15. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al. Risk for new vertebral fracture in the year following a fracture. JAMA. 2001; 285: 320-323. PMID: 11176842
16. Van Geel TACM, van Helden S, Geusens PP, Winkens B, Dinant GJ. Clinical subsequent fractures cluster in time after first fracture. Ann Rheum Dis. 2009; 68: 99-102. doi: 10.1136/ard.2008.092775 PMID: 18677009
17. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344: 1434-1441. PMID: 11346808
18. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med. 2007; 357:nihpa40967.
19. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial research group. Lancet. 1996; 348: 1535-1541. PMID: 8950879
20. Cummings SR, San Martin J, Mc Clung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009; 361: 756-765. doi: 10.1056/NEJMoa0809493 PMID: 19671655
21. Siris ES, Gehlbach S, Adachi JD, Boonen S, Chapurlat RD, Compston JE, et al. Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Ostoporosis in Women (GLOW). Osteoporos Int. 2011; 22: 27-35. doi: 10.1007/s00198-010-1211-8 PMID: 20358360
22. Giangregorio L, Papaioannou A, Thabane L, deBeer J, Cranney A, Dolovich L, et al. Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskeletal Disorders. 2008; 9: 38. doi: 10.1186/1471-2474-9-38 PMID: 18366716
23. Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364: 1728-1737. doi: 10.1056/NEJMoa1010650 PMID: 21542743
24. Brody JE. Revisiting bone drugs and femur fractures. New York Times. 6 March 2011.
25. Sambrook PH, Jiang SC, Simpson JM, March LM. Impact of adverse news media on prescriptions for osteoporosis: effects on fractures and mortality. Med J Aust. 2010; 193: 154-156. PMID: 20678043
26. The PloS Medicine Editors. Qualitative Research: Understanding patients' needs and experiences. PloS Medicine 2007; 4(8):e258. Available: doi: http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040258 PMID: 17760496
27. Glaser BG, Strauss AL. The Discovery of Grounded Theory. Strategies for Qualitative Research. Chicago: Aldine; 1967.
28. Mays N, Pope C. Qualitative Research: Rigour and Qualitative research. BMJ. 1995; 311: 109. PMID: 7613363
29. Mays N, Pope C. Qualitative research in health care: Assessing quality in qualitative research. BMJ. 2000 Jan 1; 320(7226): 50-52 PMID: 10617534
30. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6): 349-357. PMID: 17872937
31. Kitzinger J. Qualitative research: Introducing focus groups. BMJ. 1995; 311: 299-302 PMID: 7633241
32. Sale JE, Bogoch E, Haruker G, Gignac M, Beaton D, Jaglal S, et al. Patient perceptions of provider barriers to post fracture secondary prevention. Osteoporos Int. 2014; 25: 2581-2589. doi: 10.1007/s00198-014-2804-4 PMID: 25082555
33. Rimes KA, Salkovskis PM. Prediction of psychological reactions to bone density screening osteoporosis using a cognitive-behavioral model of heath anxiety. Behav Res Ther. 2002; 40: 359-381. PMID: 12002895
34. Roux C. Osteopenia: is it a problem? Int J Clin Rheumatol 2009; 4: 651-655.
35. Majumdar SR, Mc Alister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, et al. Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from tow controlled trials. Osteoporos int. 2014; 25: 2173-2179. doi: 10.1007/s00198-014-2728-z PMID: 24803330
36. Sale JEM, Gignac MA, Frankel L, Hawker G, Beaton D, Elliot-Gibson V, et al. Patients reject the concept of fragility fracture - a new understanding based on fracture patients' communication. Osteoporos Int. 2012; 23: 2829-2834. doi: 10.1007/s00198-012-1914-0 PMID: 22310958
37. Sale JEM, Gignac MA, Hawker G, Beaton D, Bogoch E, Webster F. Non pharmacological strategies used by patients at high risk for future fracture to manage fracture risk - a qualitative study. Osteoporos Int. 2014; 25: 281-288. doi: 10.1007/s00198-013-2405-7 PMID: 23740423
38. Peeters G, Tett SE, Duncan EL, Mishra GD, Dobson AJ. Osteoporosis medication dispensing fo older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy. Pharmacoepidemiol and Drug Saf. 2010; 23: 1303-1311.
39. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996 Aug 10; 348(9024): 383-6. Review.
40. Haynes RB, McKibbon KA, Kanani R. Erratum: Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications in: Lancet 1997 Apr 19;349(9059): 1180. PMID: 8709739
41. Tong A., Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Medical Research Methodology. 2012; 12: 181. doi: 10.1186/1471-2288-12-181 PMID: 23185978
42. Barbour SR. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001 May 5; 322(7294): 1115-1117. PMID: 11337448
43. Hoang-Kim A, Schemitsch Z, Sale JEM, Beaton D, Warmington K, Kulkarni AV, et al. Understanding osteoporosis and fractures: an introduction to the use of qualitative research. Arch Orthop Trauma Surg. 2014; 134: 207-217. doi: 10.1007/s00402-013-1799-1 PMID: 23860671
44. Marinker M, Blenkinsopp A, Bond C, Britten N, Feely M, George C, et al. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain; 1997.
45. Meadows LM, Mrkonjic LA, O'Brien MD, Tink W. The importance of communication in secondary fragility fracture treatment and prevention. Osteoporos Int. 2007; 18: 159-166. PMID: 16983457